Senior Director of Medical Affairs Lead Medical Science Liaison

• Assist in the development and execution of the US Medical Affairs strategy across the AiCuris antiviral portfolio encompassing marketed and pipeline products.
• Oversee field medical strategy and operations for pritelivir including the US MSL team and the Medical Affairs Fellowship Program (beginning July 2026). Provide leadership and strategic oversight for medical communications and manage relationships with vendors providing medical communication services and medical information with cross-functional teams (Commercial Clinical Development Regulatory Market Access) to ensure integrated launch readiness.
• Work with cross functional teams to develop AiCuris Areas of Interest to provide. direction for investigator-initiated study programs and manage medical grants program.
• Create training programs and educational materials for the US MSL team.
• Establish metrics and systems to measure medical affairs impact and to present these metrics to senior management.
• Act as the lead with potential global partners who will educate and market pritelivir outside the United States.

• PhD PharmD or DNP in a clinical or scientific discipline.
• 15 years of Medical Affairs experience in roles with increasing responsibility and accountability for medical affairs strategic planning & tactical execution.
• 5 years of experience leading Medical Affairs teams across multiple products or within complex therapeutic areas.
• Demonstrated experience in developing and executing medical strategies for both marketed and pipeline assets.
• Deep understanding of medical engagement regulatory environment field medical operations and scientific communication.

• Track record of building and leading high-performing teams with a focus on talent development and inclusive leadership.
• Experience in hematology/oncology infectious disease or specialty products.
• Proven experience and success in product launches.
• Comfort working in a fast-paced matrixed environment with high strategic visibility.

• Unique corporate culture:Scientific excellence a collaborative working environment and the passion to improve the lives of patients defines our work. With us you can work together with innovation awarded experts with the proven ability to translate science into commercial success. You can expect diversity inspiration as well as trustful collaboration.
• Development: We encourage people to grow and strongly support individual development and learning opportunities.
• Flexibility: Embracing flexible working accommodations we enable our people to integrate business into their personal life.
• Benefits: Competitive comprehensive benefit plan.

AiCuris is meeting the needs of the growing population of immunocompromised people who require precise therapies to effectively treat infection. Our flagship product PREVYMIS marketed by our partner MSD treats CMV in a defined group of transplant recipients. Our pivotal phase 3 candidate Pritelivir aims to address recurrent and resistant HSV infections in a broad population of patients with weakened immune systems. For immunocompromised people an otherwise manageable infection can mean life or death. AiCuris with its expertise and growing pipeline is committed to providing therapeutic solutions for them now and in the future.